Gain Therapeutics Inc. WT Exp 11/24/28
13F holders, Q3 2025 (September 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Gain Therapeutics Inc. WT Exp 11/24/28 in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holder was Gleason Group, Inc. ($0).
- Company
- Gain Therapeutics Inc. WT Exp 11/24/28
- CUSIP
- 36269B113
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Gleason Group, Inc. | 0.00% | No change | 7,481 | $0 |
"% of holder's portfolio" is GAIN THERAPEUTICS INC WT EXP 11/24/28's weight in each manager's 13F, not the share of Gain Therapeutics Inc. WT Exp 11/24/28 the manager owns.